DAVENPORT & Co LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 96 filers reported holding ARATANA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$262,0000.0%50,7500.0%0.00%0.0%
Q2 2019$262,000
-15.8%
50,750
-41.2%
0.00%
-25.0%
Q1 2019$311,000
-44.4%
86,250
-5.5%
0.00%
-50.0%
Q4 2018$559,000
-28.1%
91,250
-31.5%
0.01%
-11.1%
Q3 2018$778,000
+26.5%
133,250
-7.9%
0.01%
+12.5%
Q2 2018$615,000
-99.9%
144,750
-16.4%
0.01%
-11.1%
Q1 2018$763,494,000
-18.0%
173,128
-2.2%
0.01%
-18.2%
Q4 2017$931,020,000
-14.7%
177,000
-0.6%
0.01%
-21.4%
Q3 2017$1,091,140,000
+109.6%
178,000
+147.2%
0.01%
+100.0%
Q2 2017$520,560,00072,0000.01%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders